Related references
Note: Only part of the references are listed.Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
Maurice Chan et al.
CLINICAL CANCER RESEARCH (2013)
Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
Corinna Eichelser et al.
CLINICAL CHEMISTRY (2013)
Circulating microRNAs in plasma as early detection markers for breast cancer
Katarina Cuk et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Assessing sample and miRNA profile quality in serum and plasma or other biofluids
Thorarinn Blondal et al.
METHODS (2013)
Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer
Rom S. Leidner et al.
PLOS ONE (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers
Weijie Chen et al.
TUMOR BIOLOGY (2013)
Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening
Vivian Langagergaard et al.
Clinical Epidemiology (2013)
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort
Ashley C. Godfrey et al.
BREAST CANCER RESEARCH (2013)
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
Chun-Wen Cheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Analysis of serum genome-wide microRNAs for breast cancer detection
Qian Wu et al.
CLINICA CHIMICA ACTA (2012)
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours
Francesca Biagioni et al.
EMBO MOLECULAR MEDICINE (2012)
Changes in miRNA expression in sera and correlation to duration of disease in patients with multifocal mucosal lichen planus
Elisabet Nylander et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2012)
Identification and Pathway Analysis of microRNAs with No Previous Involvement in Breast Cancer
Sandra Romero-Cordoba et al.
PLOS ONE (2012)
Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
Michael G. Schrauder et al.
PLOS ONE (2012)
Comparing the MicroRNA Spectrum between Serum and Plasma
Kai Wang et al.
PLOS ONE (2012)
Small RNAs have a large impact Circulating microRNAs as biomarkers for human diseases
Matthew Weiland et al.
RNA BIOLOGY (2012)
Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours
Victoria J. Cookson et al.
CELLULAR ONCOLOGY (2012)
Differential expression of miRNAs in the serum of patients with high-risk oral lesions
Sara Ann MacLellan et al.
CANCER MEDICINE (2012)
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
Eleni van Schooneveld et al.
BREAST CANCER RESEARCH (2012)
Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs
Steffen G. Jensen et al.
BMC GENOMICS (2011)
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Sota Asaga et al.
CLINICAL CHEMISTRY (2011)
STABILITY INVESTIGATIONS OF MULTIVARIABLE REGRESSION MODELS DERIVED FROM LOW- AND HIGH-DIMENSIONAL DATA
Willi Sauerbrei et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2011)
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans
Pai-Sheng Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Haemolysis during Sample Preparation Alters microRNA Content of Plasma
Michaela B. Kirschner et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
Fengjun Wang et al.
GYNECOLOGIC ONCOLOGY (2010)
Improved microRNA quantification in total RNA from clinical samples
Ditte Andreasen et al.
METHODS (2010)
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
Evan M. Kroh et al.
METHODS (2010)
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Hua Zhao et al.
PLOS ONE (2010)
Roles of small RNAs in tumor formation
Gianpiero Di Leva et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Carina Roth et al.
BREAST CANCER RESEARCH (2010)
MicroRNAs: Control and Loss of Control in Human Physiology and Disease
Min Li et al.
WORLD JOURNAL OF SURGERY (2009)
A novel and universal method for microRNA RT-qPCR data normalization
Pieter Mestdagh et al.
GENOME BIOLOGY (2009)
Danish Breast Cancer Cooperative Group - DBCG: History, organization, and status of scientific achievements at 30-year anniversary
Mogens Blichert-Toft et al.
ACTA ONCOLOGICA (2008)
Elevated free IGF2 levels in localized, early-stage breast cancer in women
Ulrick Espelund et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Mammography facility characteristics associated with interpretive accuracy of screening mammography
Stephen Taplin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Diagnostic accuracy of digital versus film mammography: Exploratory analysis of selected population subgroups in DMIST
Etta D. Pisano et al.
RADIOLOGY (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
Adapting Prediction Error Estimates for Biased Complexity Selection in High-Dimensional Bootstrap Samples
Harald Binder et al.
Statistical Applications in Genetics and Molecular Biology (2008)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:: BIG 1-98
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The possible premalignant character of oral lichen planus and oral lichenoid lesions: A prospoctive five-year follow-up study of 192 patients
E. H. van der Meij et al.
ORAL ONCOLOGY (2007)
Boosting ridge regression
Gerhard Tutz et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography (vol 138, pg 168, 2003)
PA Carney et al.
ANNALS OF INTERNAL MEDICINE (2003)
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography
PA Carney et al.
ANNALS OF INTERNAL MEDICINE (2003)
Share Paper
